High-resolution structures explain the mechanism of human PNPase and provide insights into mutations causing hereditary ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

Nasal nanodrops carrying gold-based spherical nucleic acids can slip into the brain and activate powerful immune pathways ...

A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach ...

Evo’s success wasn’t limited to proteins. When they tested a different toxin that had an RNA-based inhibitor, the system ...

Around 80% of proteins involved in diseases like cancer and neurodegenerative illnesses do not have a stable structure. These proteins, known as intrinsically disordered proteins (IDPs) can quickly ...

Explore how the YB1 protein's intrinsic disorder helps it perform crucial cellular functions, impacting cancer therapies.

A groundbreaking nasal drop therapy is offering new hope for glioblastoma patients. This innovative treatment bypasses the ...

Multifunctional proteinThe study focused on a folded segment known as the cold-shock domain (CSD/CSDex) within the YB1 protein, an IDP with multiple ...

An archaeon reads the same codon in two different ways, overturning a doctrine that has stood for 60 years. Living organisms ...

When International Institute for Nanotechnology director and chemistry Prof. Chad Mirkin found out last week that he would be the recipient of the 2023-2024 Harvey Prize in Science and Technology, he ...

Intellicule, a software company founded and led by Purdue University researchers, will use an SBIR Phase I grant from the NIH ...